PrecisionLife is sponsoring the Precision Medicine Leaders Summit series’ virtual event, Precision Medicine Outside of Oncology.
Delivered digitally, the free to attend event will focus on the application of precision medicine in new areas beyond oncology with talks from leaders in biotech, pharmaceuticals, diagnostics, clinical research, healthcare and regulatory bodies.
Dr Steve Gardner, PrecisionLife CEO and Co-founder, is presenting a session titled: Precision Drug Discoveryfor Chronic Diseases.
In the last decade, fewer than 10% of the targets investigated in drug discovery programs have led to approved drugs. The ‘blockbuster’ discovery strategy does not work well for complex, chronic diseases, leading to expensive late-stage clinical trial failures, mainly due to inability to demonstrate clinical efficacy in patients.
A new precision medicine approach, driven by high-resolution patient stratification insights, goes beyond AI drug discovery to offer a faster, cheaper, and derisked opportunity to bring to market new medicines that address significant pockets of unmet medical need, maximizing the benefits of precision medicines for both drug inventors and patients.
In this presentation, you will learn how this new approach to precision medicine is pioneering the development of better, more personalized therapy options:
Join us for the Precision Medicine Outside Oncology Summit to learn more.